United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

bi-coastal pharma international llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

twi pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

zo skin health, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 0.04 g in 1 g - for the gradual bleaching of hyperpigmented skin conditions such as cholasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any other ingredient in this product. the safety of topical hydroquinone use during pregnancy or in children (21 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

nivagen pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 4% cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established. safety and effectiveness for pediatric patients below the age of 12 years have not been established.

United States - English - NLM (National Library of Medicine)

twi pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% time release cream is indicated for the gradual treatment of ultraviolet induced dyschromia and discoloration (such as chloasma, melasma, freckles, and senile lentigines) resulting from the use of oral contraceptives, pregnancy, hormone replacement therapy, or skin trauma. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or on children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 4% cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established. safety and effectiveness for pediatric patients below the age of 12 years have not been established.

United States - English - NLM (National Library of Medicine)

akron pharma inc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% skin bleaching cream  is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established. safety and effectiveness for pediatric patients below the age of 12 years have not been established.

United States - English - NLM (National Library of Medicine)

avpak - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 4% cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established. safety and effectiveness for pediatric patients below the age of 12 years have not been established.